Leonhardt Ventures Heart Failure Technology Showcase Orlando, Florida

First heart pacemaker able to recruit stem cells to damaged heart tissue - THE MYOSTIM PACER - will be introduced

News provided by

Sep 20, 2013, 08:35 ET

SANTA MONICA, Calif., Sept. 20, 2013 /PRNewswire/ -- Leonhardt Ventures will showcase its cardiovascular and heart disease related technologies Tuesday, September 24th, 7pm to 8pm @ The Westin Hotel - Nona Room, 9501 Universal Boulevard, Orlando, Florida 32819. Conveniently located walking distance from the Heart Failure Society of America Annual Meeting that takes place September 22nd to 25^th. Please RSVP to Ms. Maddy Clemens, at [email protected],

Heart Failure Treatment Related Technologies to be showcased include:

MyoStim Pacers – http:/www.myostimpacers.com - world's first heart failure pacemaker designed to recruit reparative stem cells to damaged and weakened heart tissue.

Bioheart, Inc. – http://www.bioheartinc.com - Phase III leader in applying adult muscle stem cells to treat advanced heart failure since 1999. Only cell type known to grow new contractile muscle in the depths of scar tissue.

BioPace – biological pacemaker made entirely of living cells.

CoroStim – world's first vibrational energy emitting pacemaker designed to prevent plaque formation in high risk coronary arteries.

AortaCell Stemergy - Wireless non-invasive energy device designed to recruit stem cells to weakened vessel wall tissue for repair.

BioLeonhardt – http://www.bioleonhardt.com - combination electrical stimulation and multi-stage cell and gene therapy method, composition and devices for treating advanced heart failure. Featuring combined utilization of MicroRNAs, nutrient time release SDF-1, hydrogel, cardiac stem cells, iPS cells and muscle progenitor stem cells. First method to utilize an implantable stem cell pump for multiple dosages of delivery of stem cells over time.

Cardiobridge – http://www.cardiobridge.com - Highest flow rate 10FR circulatory support catheter pump in clinical testing for acute decompensating heart failure and high-risk PCI. Data on 30 clinical patients will be presented.

Procyrion Implantable Heart Pumps - www.procyrion.com - The Procyrion device consists of a small, continuous flow pump mounted within a self-expanding anchoring system. The device is advanced through a catheter in the femoral artery to the descending thoracic aorta. The self-expanding anchors deploy to fix the pump to the aortic wall.

HeartScore - www.heartscore.co – Composite scoring system of genetic, blood and artery scan test results that are loaded into the SecondBeat wearable wrist watch for a baseline score. The watch has an infrared sensor that measures real time endothelial health. The baseline score goes up or down if the patient eats well, exercises well and is in compliance with all doctor prescribed medicines and protocols. The composite HeartScore is clearly viewable to patients to help real time guidance of their heart and cardiovascular health.

Stem Cell Pump - world's first implantable stem cell pump designed for controlled dose delivery of stem cells and selected growth factors over time to specific target organ locations.

LVSens – Implantable heart sensor.

The Leonhardt Ventures Cal-X Stars Innovation Accelerator Scientific Advisory Board made up of leading heart failure physicians, stem cell scientists, cardiologists and electrophysiologists will meet privately immediately following the technology showcase at the same location - http://calxstars.com/scientific-advisory-board/. Leonhardt Vineyards (www.leonhardtvineyards.com) gold medal winning wines will be served.

About Leonhardt Ventures: Since 1982 Leonhardt Ventures has a strong history of inventing, developing, backing and bringing to market leadership products for treating heart and cardiovascular disease. Over 200,000 patients have been treated to date with Leonhardt inventions. Leonhardt Venture's started the Cal-X Stars Innovation and Business Accelerator in 2012 to guide forward cardiovascular and social good impact innovations over a 5 year period in preparation for a listing on the future California Stock Exchange (SEC registration application in process). June 11th, 2013 Leonhardt Ventures announced that it has chosen Core Manufacturing in Valencia, California for manufacturing and product development services for its lineup of active implantable devices - http://online.wsj.com/article/PR-CO-20130611-906181.html

Contact: Howard Leonhardt, Leonhardt Ventures, 1531 6^th Street, Unit 401, Santa Monica, California, 90401, Office direct 310 310 2534, Email

This PR distribution was issued via PR Syndication.

SOURCE Leonhardt Ventures

RELATED LINKS
http://www.leonhardtventures.com

http://www.calxstars.com

http://www.myostimpacers.com

http://www.bioheartinc.com